Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Duffau

Showing results (41-50 of 113) with videos related to

Pageof 12
Sort By:
Clinical Reviews in Allergy & Immunology|June 30, 2019
Platelets and IgE: Shaping the Innate Immune Response in Systemic Lupus ErythematosusBenoit Brilland, Marc Scherlinger, Liliane Khoryati, et al.
Autoimmunity Reviews|April 11, 2018
Systemic lupus erythematosus and systemic sclerosis: All roads lead to plateletsMarc Scherlinger, Vivien Guillotin, Marie-Elise Truchetet, et al.
Arthritis Research & Therapy|December 24, 2010
Steady-state mycophenolate mofetil pharmacokinetic parameters enable prediction of systemic lupus erythematosus clinical flares: an observational cohort studySarah Djabarouti, Dominique Breilh, Pierre Duffau, et al.
Expert Opinion on Pharmacotherapy|March 10, 2010
Therapeutic drug monitoring of mycophenolate mofetil and enteric-coated mycophenolate sodium in patients with systemic lupus erythematosusSarah Djabarouti, Pierre Duffau, Estibaliz Lazaro, et al.
Annals of the Rheumatic Diseases|January 6, 2019
Rituximab in moderate to severe non-renal systemic lupus erythematosus: a reanalysis of the EXPLORER studyMarc Scherlinger, Claire Carcaud, Marie-Elise Truchetet, et al.
Plos One|April 7, 2016
Incidence and Risk Factors for Severe Bacterial Infections in People Living with HIV. ANRS CO3 Aquitaine Cohort, 2000-2012Amandine Collin, Fabien Le Marec, Marie-Anne Vandenhende, et al.
Frontiers in Immunology|November 16, 2020
Elevated Circulatory Levels of Microparticles Are Associated to Lung Fibrosis and Vasculopathy During Systemic SclerosisDamien Leleu, Emeline Levionnois, Paoline Laurent, et al.
Autoimmunity Reviews|July 20, 2019
Prolonged remission in SLE is possible by using reduced doses of prednisone: An observational study from the Lupus-Cruces and Lupus-Bordeaux inception cohortsGuillermo Ruiz-Irastorza, Beatriz Ruiz-Estevez, Estibaliz Lazaro, et al.
BMC Pulmonary Medicine|May 9, 2025
CD4/CD8 T-cell ratio in bronchoalveolar lavage fluid as a marker of sarcoidosis severity: a retrospective studyThibaut Zannese, Jean-François Viallard, Soumaya Sridi-Cheniti, et al.
Joint Bone Spine|November 5, 2020
The impact of clopidogrel on plasma-soluble CD40 ligand levels in systemic lupus erythematosus patients: the CLOPUS phase I/II pilot studyGuillaume Vial, Noémie Gensous, Hélène Savel, et al.
Pageof 12

Showing results (41-50 of 113) with videos related to

Sort By:
Pageof 12
Clinical Reviews in Allergy & Immunology|June 30, 2019
Platelets and IgE: Shaping the Innate Immune Response in Systemic Lupus ErythematosusBenoit Brilland, Marc Scherlinger, Liliane Khoryati, et al.
Autoimmunity Reviews|April 11, 2018
Systemic lupus erythematosus and systemic sclerosis: All roads lead to plateletsMarc Scherlinger, Vivien Guillotin, Marie-Elise Truchetet, et al.
Arthritis Research & Therapy|December 24, 2010
Steady-state mycophenolate mofetil pharmacokinetic parameters enable prediction of systemic lupus erythematosus clinical flares: an observational cohort studySarah Djabarouti, Dominique Breilh, Pierre Duffau, et al.
Expert Opinion on Pharmacotherapy|March 10, 2010
Therapeutic drug monitoring of mycophenolate mofetil and enteric-coated mycophenolate sodium in patients with systemic lupus erythematosusSarah Djabarouti, Pierre Duffau, Estibaliz Lazaro, et al.
Annals of the Rheumatic Diseases|January 6, 2019
Rituximab in moderate to severe non-renal systemic lupus erythematosus: a reanalysis of the EXPLORER studyMarc Scherlinger, Claire Carcaud, Marie-Elise Truchetet, et al.
Plos One|April 7, 2016
Incidence and Risk Factors for Severe Bacterial Infections in People Living with HIV. ANRS CO3 Aquitaine Cohort, 2000-2012Amandine Collin, Fabien Le Marec, Marie-Anne Vandenhende, et al.
Frontiers in Immunology|November 16, 2020
Elevated Circulatory Levels of Microparticles Are Associated to Lung Fibrosis and Vasculopathy During Systemic SclerosisDamien Leleu, Emeline Levionnois, Paoline Laurent, et al.
Autoimmunity Reviews|July 20, 2019
Prolonged remission in SLE is possible by using reduced doses of prednisone: An observational study from the Lupus-Cruces and Lupus-Bordeaux inception cohortsGuillermo Ruiz-Irastorza, Beatriz Ruiz-Estevez, Estibaliz Lazaro, et al.
BMC Pulmonary Medicine|May 9, 2025
CD4/CD8 T-cell ratio in bronchoalveolar lavage fluid as a marker of sarcoidosis severity: a retrospective studyThibaut Zannese, Jean-François Viallard, Soumaya Sridi-Cheniti, et al.
Joint Bone Spine|November 5, 2020
The impact of clopidogrel on plasma-soluble CD40 ligand levels in systemic lupus erythematosus patients: the CLOPUS phase I/II pilot studyGuillaume Vial, Noémie Gensous, Hélène Savel, et al.
Pageof 12